AgNP-PVP-meglumine antimoniate nanocomposite reduces Leishmania amazonensis infection in macrophages
Abstract Background Leishmaniasis is an infectious disease caused by parasites of the genus Leishmania and presents different clinical manifestations. The adverse effects, immunosuppression and resistant strains associated with this disease necessitate the development of new drugs. Nanoparticles hav...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2021-07-01
|
| Sarja: | BMC Microbiology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12866-021-02267-2 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
